Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos D Vassilakis

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Mediterranean Journal of Rheumatology|February 20, 2025
Difficult to Treat Psoriatic Arthritis: The Road So FarAngeliki E Dimopoulou, Konstantinos D Vassilakis, George E Fragoulis
Rheumatology International|March 26, 2026
Glucocorticoid-induced diabetes mellitus: mechanisms, risk factors, and clinical pathways with insights from autoimmune rheumatic diseasesMaria Soura, Amalia Bakiri, George E Fragoulis, et al.
The Lancet. Rheumatology|December 4, 2025
Skin cancer in inflammatory arthritis: should we advise screening?Konstantinos D Vassilakis, Kyriaki Lampadaki, Elena Nikiphorou, et al.
Mediterranean Journal of Rheumatology|May 17, 2024
Selective JAK-Inhibitors in SpondyloarthritisKonstantinos D Vassilakis, Konstantina Magiouf, Stefan Siebert, et al.
Annals of the Rheumatic Diseases|September 13, 2025
Antiobesity medications in rheumatology. Quo vadis?Niki Kyriazi, Konstantinos D Vassilakis, Amalia Bakiri, et al.
Mediterranean Journal of Rheumatology|February 6, 2026
Cycling or Swapping in Spondyloarthritis? Current KnowledgeSofia Karagianni, Niki Kyriazi, Nikolaos Michalakeas, et al.
Therapeutic Advances in Musculoskeletal Disease|September 24, 2024
Monotherapy or combination therapy in PsA: current aspectsElpida Skouvaklidou, Paraskevi Avgerou, Konstantinos D Vassilakis, et al.
Rheumatology (Oxford, England)|August 17, 2024
Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitorsTheodoros Androutsakos, Konstantinos Dimitriadis, Maria-Loukia Koutsompina, et al.
Rheumatology (Oxford, England)|November 27, 2024
Comment on: 'Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors': replyTheodoros Androutsakos, Konstantinos Dimitriadis, Maria-Loukia Koutsompina, et al.
Autoimmunity Reviews|March 6, 2026
Enthesitis in Spondyloarthritis. From pathogenesis to clinical presentation and imaging: Similarities and differences between PsA and axSpAIoannis Xynogalas, Anastasios Karamanakos, Artemis Galani, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Mediterranean Journal of Rheumatology|February 20, 2025
Difficult to Treat Psoriatic Arthritis: The Road So FarAngeliki E Dimopoulou, Konstantinos D Vassilakis, George E Fragoulis
Rheumatology International|March 26, 2026
Glucocorticoid-induced diabetes mellitus: mechanisms, risk factors, and clinical pathways with insights from autoimmune rheumatic diseasesMaria Soura, Amalia Bakiri, George E Fragoulis, et al.
The Lancet. Rheumatology|December 4, 2025
Skin cancer in inflammatory arthritis: should we advise screening?Konstantinos D Vassilakis, Kyriaki Lampadaki, Elena Nikiphorou, et al.
Mediterranean Journal of Rheumatology|May 17, 2024
Selective JAK-Inhibitors in SpondyloarthritisKonstantinos D Vassilakis, Konstantina Magiouf, Stefan Siebert, et al.
Annals of the Rheumatic Diseases|September 13, 2025
Antiobesity medications in rheumatology. Quo vadis?Niki Kyriazi, Konstantinos D Vassilakis, Amalia Bakiri, et al.
Mediterranean Journal of Rheumatology|February 6, 2026
Cycling or Swapping in Spondyloarthritis? Current KnowledgeSofia Karagianni, Niki Kyriazi, Nikolaos Michalakeas, et al.
Therapeutic Advances in Musculoskeletal Disease|September 24, 2024
Monotherapy or combination therapy in PsA: current aspectsElpida Skouvaklidou, Paraskevi Avgerou, Konstantinos D Vassilakis, et al.
Rheumatology (Oxford, England)|August 17, 2024
Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitorsTheodoros Androutsakos, Konstantinos Dimitriadis, Maria-Loukia Koutsompina, et al.
Rheumatology (Oxford, England)|November 27, 2024
Comment on: 'Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors': replyTheodoros Androutsakos, Konstantinos Dimitriadis, Maria-Loukia Koutsompina, et al.
Autoimmunity Reviews|March 6, 2026
Enthesitis in Spondyloarthritis. From pathogenesis to clinical presentation and imaging: Similarities and differences between PsA and axSpAIoannis Xynogalas, Anastasios Karamanakos, Artemis Galani, et al.
Pageof 2